p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior

Cancer Research

Volumn 71, Issue 20, 2011, Pages 6338-6349

  Rosenthal, Devin T ^a,b   Iyer, Harish ^b   Escudero, Silvia ^d   Bao, Liwei ^a   Wu, Zhifen ^a   Ventura, Alejandra C ^e   Kleer, Celina G ^a,b,c   Arruda, Ellen M ^b   Garikipati, Krishna ^b   Merajver, Sofia D ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e INSTITUTO DE FISIOLOGÍA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SERINE THREONINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; CYTOSKELETON; FINITE ELEMENT ANALYSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UBIQUITINATION; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL MOVEMENT; COMPUTER SIMULATION; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 12; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; RHO GTP-BINDING PROTEINS;

EID: 80054030191     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1291     Document Type: Article

References (48)

1. Burstein HJ, Polyak K, Wong JS, Lester SC, Kaelin CM. Ductal carcinoma in situ of the breast. N Engl J Med 2004;350:1430-41. (Pubitemid 38419997)
2. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40. (Pubitemid 32225829)
3. Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007;1773:1358-75.
4. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998;273:2161-8. (Pubitemid 28069266)
5. Platanias LC. Map kinase signaling pathways and hematologic malignancies. Blood 2003;101:4667-79. (Pubitemid 36857719)
6. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537-49.
7. Qi X, Pohl NM, Loesch M, Hou S, Li R, Qin JZ, et al. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin- proteasome pathways in regulating Ras transformation and stress response. J Biol Chem 2007;282:31398-408. (Pubitemid 350044894)
8. Tortorella LL, Lin CB, Pilch PF. ERK6 is expressed in a developmentally regulated manner in rodent skeletal muscle. Biochem Biophys Res Commun 2003;306:163-8. (Pubitemid 36629421)
9. Cuenda A, Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 1999;274:4341-6.
10. Wang XS, Diener K, Manthey CL, Wang S, Rosenzweig B, Bray J, et al. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J Biol Chem 1997;272:23668-74. (Pubitemid 27410940)
11. Li Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996;228:334-40. (Pubitemid 26396075)
12. Tang J, Qi X, Mercola D, Han J, Chen G. Essential role of p38gamma in K-Ras transformation independent of phosphorylation. J Biol Chem 2005;280:23910-7. (Pubitemid 40884879)
13. Loesch M, Chen G. The p38 MAPK stress pathway as a tumor suppressor or more? Front Biosci 2008;13:3581-93. (Pubitemid 351606106)
14. Qi X, Tang J, Loesch M, Pohl N, Alkan S, Chen G. p38gamma mitogen-activated protein kinase integrates signaling crosstalk between Ras and estrogen receptor to increase breast cancer invasion. Cancer Res 2006;66:7540-7. (Pubitemid 44289209)
15. Loesch M, Zhi HY, Hou SW, Qi XM, Li RS, Basir Z, et al. p38{gamma} MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9. J Biol Chem 2010;285:15149-58.
16. Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001;94:1-5. (Pubitemid 32801745)
17. McCabe A, Dolled-Filhart M, Camp RL, Rimm DL. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 2005;97:1808-15. (Pubitemid 43033901)
18. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol 1997;7:353-61. (Pubitemid 27384781)
19. Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998;273:1741-8. (Pubitemid 28133705)
20. Ladwein M, Rottner K. On the Rho'd: the regulation of membrane protrusions by Rho-GTPases. FEBS Lett 2008;582:2066-74.
21. Rajah TT, Abidi SM, Rambo DJ, Dmytryk JJ, Pento JT. The motile behavior of human breast cancer cells characterized by time-lapse videomicroscopy. In Vitro Cell Dev Biol Anim 1998;34:626-8. (Pubitemid 29069596)
22. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. Fourier analysis of cell motility: correlation of motility with metastatic potential. Proc Natl Acad Sci U S A 1989;86:1254-8. (Pubitemid 19061525)
23. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53-62.
24. Wheeler AP, Ridley AJ. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004;301:43-9. (Pubitemid 39388895)
25. Hakem A, Sanchez-Sweatman O, You-Ten A, Duncan G, Wakeham A, Khokha R, et al. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005;19:1974-9. (Pubitemid 41247955)
26. Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res 2010;16:5222-32.
27. Simon C, Goepfert H, Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res 1998;58:1135-9. (Pubitemid 28183199)
28. Chen L, Mayer JA, Krisko TI, SpeersCW, Wang T, Hilsenbeck SG, et al. Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res 2009;69:8853-61.
29. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, et al. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. EMBO J 2005;24:1134-45. (Pubitemid 40516597)
30. Kim JH, Cho A, Yin H, Schafer DA, Mouneimne G, Simpson KJ, et al. Psidin, a conserved protein that regulates protrusion dynamics and cell migration. Genes Dev 2011;25:730-41.
31. Weiner OD, Marganski WA, Wu LF, Altschuler SJ, Kirschner MW. An actin-based wave generator organizes cell motility. PLoS Biol 2007;5:e221.
32. Del Alamo JC, Meili R, Alonso-Latorre B, Rodriguez-Rodriguez J, Aliseda A, Firtel RA, et al. Spatio-temporal analysis of eukaryotic cell motility by improved force cytometry. Proc Natl Acad Sci U S A 2007;104:13343-8. (Pubitemid 47293947)
33. Barnhart EL, Allen GM, Julicher F, Theriot JA. Bipedal locomotion in crawling cells. Biophys J 2010;98:933-42.
34. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelialmesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
35. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39. (Pubitemid 38798858)
36. Chiang AC, Massague J. Molecular basis of metastasis. N Engl J Med 2008;359:2814-23.
37. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 2000;60:5832-8.
38. Wu M, Wu ZF, Merajver SD. Rho proteins and cell-matrix interactions in cancer. Cells Tissues Organs 2007;185:100-3. (Pubitemid 46956849)
39. van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis 2002;19:301-11. (Pubitemid 34606755)
40. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000;406:532-5. (Pubitemid 30625739)
41. Ikoma T, Takahashi T, Nagano S, Li YM, Ohno Y, Ando K, et al. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice. Clin Cancer Res 2004;10:1192-200. (Pubitemid 38198921)
42. Islam M, Lin G, Brenner JC, Pan Q, Merajver SD, Hou Y, et al. RhoC expression and head and neck cancer metastasis. Mol Cancer Res 2009;7:1771-80.
43. Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Characterization of the roles of RhoC and RhoA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers. Cancer 2010;116:2768-82.
44. Ridley AJ. Rho GTPases and cell migration. J Cell Sci 2001;114:2713-22. (Pubitemid 32785451)
45. Rosenthal DT, Brenner JC, Merajver SD. Rho proteins in cancer. In: van Golen KL, editor. The Rho GTPases in cancer. New York: Springer New York; 2010. p. 29-42.
46. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005;19:362-70. (Pubitemid 40316524)
47. Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem 2010;285:7288-99.
48. Nethe M, Hordijk PL. The role of ubiquitylation and degradation in RhoGTPase signalling. J Cell Sci 2010;123:4011-8.